Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1 beta/IL-17A axis | |
Ning, C.[1]; Li, Y-Y[2]; Wang, Y.[3]; Han, G-C[4]; Wang, R-X[5]; Xiao, H.[6]; Li, X-Y[7]; Hou, C-M[8]; Ma, Y-F[9]; Sheng, D-S[10] | |
刊名 | MUCOSAL IMMUNOLOGY |
2015 | |
卷号 | 8期号:6页码:1275-1284 |
ISSN号 | 1933-0219 |
DOI | http://dx.doi.org/10.1038/mi.2015.18 |
URL标识 | 查看原文 |
收录类别 | SCI(E) ; PUBMED |
WOS记录号 | WOS:000367629100009 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5209237 |
专题 | 河南大学 |
作者单位 | 1.[1]Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China. 2.State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China. 3.[2]Henan Univ, Sch Med, Inst Immunol, Kaifeng, Peoples R China. 4.[3]Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China. 5.[4]Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China. 6.State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China. 7.[5]Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China. 8.State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China. 9.[6]Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China. 10.State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China. |
推荐引用方式 GB/T 7714 | Ning, C.[1],Li, Y-Y[2],Wang, Y.[3],et al. Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1 beta/IL-17A axis[J]. MUCOSAL IMMUNOLOGY,2015,8(6):1275-1284. |
APA | Ning, C.[1].,Li, Y-Y[2].,Wang, Y.[3].,Han, G-C[4].,Wang, R-X[5].,...&Chen, G-J[15].(2015).Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1 beta/IL-17A axis.MUCOSAL IMMUNOLOGY,8(6),1275-1284. |
MLA | Ning, C.[1],et al."Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1 beta/IL-17A axis".MUCOSAL IMMUNOLOGY 8.6(2015):1275-1284. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论